Expert Commentary

Webcast: Oral contraceptives and breast cancer: What’s the risk?

OBG Manag. 2016 June;28(6)
By
Ronald T. Burkman, MD
Author and Disclosure Information

Does the use of oral contraceptives, particularly the presence of estrogen and progesterone, increase the risk of breast cancer? And what about a patient who has a BRCA gene mutation, is her risk altered by her genetic mutation? What the data tell us.

 

Access Dr. Burkman's Webcasts on contraception:

Helpful resource for your practice:

Recommended Reading

The Perfect Storm: Delivery system reform and precision medicine for all
MDedge ObGyn
Tamoxifen benefits premenopausal breast cancer patients
MDedge ObGyn
‘Extreme’ monitoring fails to boost survival in breast cancer patients
MDedge ObGyn
Full course of AI keeps disease at bay longer
MDedge ObGyn
High ER expression + high RS spells high risk for late distant recurrence
MDedge ObGyn
ASCO issues guidelines for HR+ metastatic breast cancer
MDedge ObGyn
Exercise linked to fewer cardiovascular events in nonmetastatic breast cancer patients
MDedge ObGyn
Targeting vagal activity could improve breast cancer survival
MDedge ObGyn
VIDEO: Doctors should be challenged to extend AIs
MDedge ObGyn
Ethnic groups differ in BRCA risk management
MDedge ObGyn

Related Articles